TIAN Shu | Department of Medical Oncology, Fudan University Shanghai Cancer Center

スポンサーリンク

概要

• TIAN Shuの詳細を見る
• 同名の論文著者
• Department of Medical Oncology, Fudan University Shanghai Cancer Centerの論文著者

関連著者

• Lou Liguang

  Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

• Li Jin

  Department Of Medical Oncology Fudan University Shanghai Cancer Center

• TIAN Shu

  Department of Medical Oncology, Fudan University Shanghai Cancer Center

• QUAN Haitian

  Shanghai Institute of Materia Medica, Chinese Academy of Sciences

• XIE Chengying

  Shanghai Institute of Materia Medica, Chinese Academy of Sciences

• GUO Haiyi

  Department of Medical Oncology, Fudan University Shanghai Cancer Center

• LU Fangfang

  Department of Medical Oncology, Fudan University Shanghai Cancer Center

• XU Yongping

  Shanghai Institute of Materia Medica, Chinese Academy of Sciences

• Tian Shu

  Department Of Medical Oncology Fudan University Shanghai Cancer Center

• Guo Haiyi

  Department Of Medical Oncology Fudan University Shanghai Cancer Center

• Lu Fangfang

  Department Of Medical Oncology Fudan University Shanghai Cancer Center

• Xu Yongping

  Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

• Quan Haitian

  Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

• Xie Chengying

  Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

• Li Jin

  Department Of Medical Oncology Cancer Hospital Fudan University

• Li Jin

  Department of Materials Science, Fudan University, 220 Handan road, Shanghai, 200433, P. R. China

もっと見る 閉じる

著作論文

• YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

スポンサーリンク